Interview with CytImmune CEO Saba Malak
Jun 17, 2021•32 min•Season 1Ep. 39
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
CytImmune Sciences is an emerging leader in cancer nanomedicine. It is a platform company with products of its own in development. CEO Saba explains the technology and why he is confident it will ultimately help patients. The company has a Phase II development collaboration with the National Cancer Institute, and is scaling up its manufacturing to be ready.
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:
- Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
- Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
- YouTube https://www.youtube.com/@CareTalkPodcast
- CareTalk website https://www.caretalkpodcast.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.
Episodes through March 2025 were produced by Dafna Williams.
For the best experience, listen in Metacast app for iOS or Android